ANI Pharmaceuticals

$30.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.03 (+3.49%) As of 7:41 PM UTC today

Why Robinhood?

You can buy or sell ANIP and other stocks, options, and ETFs commission-free!

About ANIP

ANI Pharmaceuticals, Inc., also called ANI Pharmaceuticals, is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN. The listed name for ANIP is ANI Pharmaceuticals, Inc.

CEO

Nikhil Lalwani

Employees

338

Headquarters

Baudette, Minnesota

Founded

1996

Market Cap

388.33M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

54.82K

High Today

$30.53

Low Today

$29.31

Open Price

$29.89

Volume

29.37K

52 Week High

$52.22

52 Week Low

$23.55

ANIP News

Benzinga4h

ANI Pharmaceuticals's Earnings: A Preview

ANI Pharmaceuticals (NASDAQ:ANIP) announces its next round of earnings this Tuesday, March 09. Here is Benzinga's everything-that-matters guide for this Tuesday

ANIP Earnings

$0.00

$0.48

$0.96

$1.44

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

$0.94 per share

Actual

Available Mar 9, Pre-Market

Preview Earnings Call